TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa
PLOS One · 2025
DOI: 10.1371/journal.pone.0333367 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Lebohang M Mlambo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, South Africa. Hauptthemen laut MEDLINE: Tuberculosis, HIV Infections, Acquired Immunodeficiency Syndrome. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, USA.
Abstract (Originalsprache)
Background
Tuberculosis (TB) remains a major global health challenge, particularly for people living with HIV/AIDS (PLWHA). TB preventive treatment (TPT) has been found to reduce the risk of TB among PLWHA. As TPT has become a standard component of HIV care, understanding client-level perceptions and knowledge of TPT is crucial to optimizing uptake.
Methods
This qualitative sub-study was conducted within a cluster-randomized trial evaluating a TPT initiation strategy in two provinces of South Africa. The qualitative component explored patient understanding and experiences with HIV, TB, and TPT through in-depth interviews. PLWHA receiving care at participating public-sector healthcare facilities in the North West and Free State provinces were systematically purposively selected. Thematic analysis was used to identify themes.
Results
Thirty-three adult PLWHA were interviewed. Most participants understood TB, household transmission risk, and that PLWHA are more susceptible to TB. Participants were aware TB is curable and associated its risk and transmission to dirty environments, neglecting flu-like symptoms and lifestyle habits (alcohol use and smoking). Participants highlighted that health-seeking behaviors, treatment adherence, and community perception influence TB burden, stressing TB prevention and treatment as community challenges. Knowledge of TPT varied, with most participants emphasizing the need for clients to take initiative in their treatment. Participants requested that healthcare workers provide more details about TPT through posters and pamphlets in clinics, and suggested community engagement to encourage uptake. While adherence was acknowledged, concerns included side effects and the burden of taking both antiretroviral therapy and TPT.
Conclusion
Individual and community social and health-related factors, along with acceptability of TPT, might affect uptake and retention. While TPT was seen as important, concerns about side effects and dual treatment burdens highlight the need for improved education and support. Strengthening healthcare communication, expanding TPT information, and promoting TPT as a proactive health decision may motivate uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, South Africa.
- Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States of America.
- African Potential Group, Johannesburg, South Africa.
- Africa Health Research Institute, Clinical Trials Unit, KwaZulu-Natal, South Africa.
- Department of Health, Johns Hopkins Bloomberg School of Public Health, Behavior, and Society, Baltimore, Maryland, United States of America.
ORCID-Profile: Lebohang M Mlambo, Kate Shearer, Limakatso Lebina
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases, USA
Zitieren
APA
Mlambo, L. M., Setlaleleng, M., Shearer, K., Mofokeng, N. J., Ndou, P., Milovanovic, M., Steiner, L., Genade, L., Lebina, L., Martinson, N. A., Hoffmann, C. J., & Owczarzak, J. (2025). TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa. PLOS One. https://doi.org/10.1371/journal.pone.0333367
Vancouver
Mlambo LM, Setlaleleng M, Shearer K, Mofokeng NJ, Ndou P, Milovanovic M, et al. TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa. PLOS One. 2025. doi:10.1371/journal.pone.0333367
BibTeX
@article{Mlambo2025,
author = {Mlambo, Lebohang M and Setlaleleng, Matshepo and Shearer, Kate and Mofokeng, Nombuyiselo J and Ndou, Phineas and Milovanovic, Minja and Steiner, Laura and Genade, Leisha and Lebina, Limakatso and Martinson, Neil A and Hoffmann, Christopher J and Owczarzak, Jill},
title = {TB will never end because of us: Experiences of TB preventive treatment among people living with HIV/AIDS in South Africa},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0333367}
}
EUVIMED